Anthropic is walking into a buzzsaw of investor skepticism as it preps a September or October IPO. The company’s stated valuation sits at a staggering $965 billion — a number that would instantly make it the benchmark for how the entire AI industry gets priced. But preliminary meetings haven’t been victory laps.
According to the Wall Street Journal, potential investors are hammering leadership with three uncomfortable questions: What happens when Chinese labs like Moonshot and Alibaba pump out models like Kimi K3 and Qwen3.8 that nearly match Western performance at a fraction of the cost? How do you navigate a Trump administration that’s openly hostile to some AI priorities? And what’s the growth plan when American communities keep fighting new data center construction?
CEO Dario Amodei’s public line has been that users want the smartest model available, period, and that Chinese systems consistently trail by months. That gap, however, looks increasingly fictional. Across benchmarks, the six-to-eight-month lead executives once touted has shrunk dramatically. When your entire valuation rests on a technology moat, that erosion isn’t theoretical — it’s existential.
Anthropic is pivoting hard on messaging. Instead of just selling API access, sources say the company will spotlight health and biology applications to counter the growing public fatigue with AI hype. On the business side, Claude Code has given them a genuine edge, pushing annualized revenue past $47 billion in May. They’ve also locked in fresh compute deals with SpaceX and Google. Yet the service has buckled under repeated outages this year, a rough look for a company asking public markets to bet on flawless execution. OpenAI is expected to follow with its own IPO, possibly next year, which means Anthropic’s debut won’t just set its own price — it’ll set the entire sector’s ceiling.
